Published online in Diabetologia, three of the four studies found some type of cancer-related association with the long-acting insulin analog.
I have a link to Diabetologia on my sidebar if you are interested in downloading the original studies.
pharmaceutical
New Byetta Studies
FDA Warning of Byetta Pancreatitis Side Effects Contradicted by New Studies – AboutLawsuits.com
Note where this original post is located. Let’s all wait and see if the FDA changes their position on the drug.
Rosiglitazone Doubles Risk of Heart Failure
Take Home Lesson:
Consider simply adding the usual recommended debits for CHF to the DM rate.
After all, the HF risk is doubled but not the mortality. And critics of this study question its statistical validity.
Actos Slows IMT
Thiazolidinediones such as pioglitazone have been shown to prevent or delay the onset of diabetes when given to patients at high risk of developing diabetes. But other studies have found that the drug class appears to inhibit the development of atherosclerosis.
Vitamin C + Insulin – New RX Possibilities for DM1
University of Oklahoma researchers shed light on treatment possibilities | NewsOK.com
The article does not reveal the number of humans studied but the findings are definitely interesting. Do watch the video because it offers additional information that is not in written form. You will be subjected to a short commercial for beef.
Ironic.
Exforge HCT
Where do they come up with these names?
Dutasteride REDUCE Trial
This study was funded by GlaxoSmithKline.
The study was conducted by a physician who is a consultant for GlaxoSmithKline.
Bye Bye Raptiva
Medical News: Raptiva Yanked from U.S. Market – in Product Alert, Prescriptions from MedPage Today
Genentech announced a “phased voluntary withdrawal” of the drug beginning immediately, advising physicians to avoid writing prescriptions for new patients and to contact those already on the drug to discuss alternative therapies.
I wonder if a “phased voluntary withdrawal” is enough to avoid the lawsuits?
ACTIVE-A = 28% Reduction in Stroke
Medical Updates – Plavix + Aspirin = New Treatment for Atrial Fibrillation | Health News
Stroke reduction of 28% is impressive.
lifeunderwriter.net 
You must be logged in to post a comment.